{
    "SPADE_N_14761": {
        "Sequence Information": {
            "Peptide Name": "AcrAP1, AP1-Z1",
            "Sequence": "FLFSLIPHAISGLISAFK",
            "Sequence Length": 18,
            "Biological Activity": [
                "Anti-Gram+",
                "Anti-Gram-",
                "Anticancer",
                "Antifungal",
                "Anti-Mammalian Cell"
            ],
            "Binding Target": "1. Lipid Bilayer",
            "Source": "1. Androctonus crassicauda",
            "Gene": "",
            "PDB ID": "",
            "UniProt Entry": [
                {
                    "uniprotId": "A0A0A1I6E7",
                    "uniprotUrl": "http://www.uniprot.org/uniprot/A0A0A1I6E7",
                    "description": "The amino acid sequence of the current peptide coincides with the part of the UniProt entry that represents a peptide precursor."
                }
            ],
            "Literature": [
                {
                    "Title": "Cationicity-enhanced analogues of the antimicrobial peptides, AcrAP1 and AcrAP2, from the venom of the scorpion, Androctonus crassicauda, display potent growth modulation effects on human cancer cell lines.",
                    "Pubmed ID": "25332684",
                    "Reference": "Int J Biol Sci. 2014;10:1097-1107",
                    "Author": "Du Q, Hou X, Ge L, Li R, Zhou M, Wang H, Wang L, Wei M, Chen T, Shaw C",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/25332684"
                },
                {
                    "Title": "In Vitro and MD Simulation Study to Explore Physicochemical Parameters for Antibacterial Peptide to Become Potent Anticancer Peptide.",
                    "Pubmed ID": "31909181",
                    "Reference": "Mol Ther Oncolytics. 2019;16:7-19",
                    "Author": "Ma R, Wong SW, Ge L, Shaw C, Siu SWI, Kwok HF",
                    "URL": "http://www.ncbi.nlm.nih.gov/pubmed/31909181"
                }
            ],
            "Mass": 1961.35,
            "PI": 8.76,
            "Net Charge": 2,
            "Hydrophobicity": 1.41,
            "Frequent Amino Acids": "FIL",
            "Absent Amino Acids": "CDEMNOQRTUVWY",
            "Basic Residues": 2,
            "Acidic Residues": 0,
            "Hydrophobic Residues": 11,
            "Polar Residues": 7,
            "Positive Residues": 2,
            "Negative Residues": 0,
            "SPADE ID": "SPADE_N_14761",
            "Similar Sequences": [
                {
                    "SPADE_ID": "SPADE_UN_11357",
                    "Similarity": 1.0,
                    "Sequence": "FLFSLIPHAISGLISAFK"
                },
                {
                    "SPADE_ID": "SPADE_N_01425",
                    "Similarity": 0.9444444444444444,
                    "Sequence": "MEIKYLLTVFLVLLIVSDHCQAFLFSLIPSAISGLISAFKGRRKRDLNGQIDHFKNFRKRDAELEELLSKLPIY"
                },
                {
                    "SPADE_ID": "SPADE_N_01438",
                    "Similarity": 0.9444444444444444,
                    "Sequence": "MEIKYLLTVFLVLLIVSDHCQAFLFSLIPSAISGLISAFKGKRRRDLNAQIDQFKNFRKRDAELEELLSKLPIY"
                }
            ],
            "Hemolytic Activity": "Horse erythrocytes:100% Hemolysis=64 µM",
            "Target Organism": "Staphylococcus aureus NCTC 10788(MIC=8µM),Staphylococcus aureus NCTC 10788(MBC=32µM),Escherichia coli NCTC 10418(MIC=>250µM),Candida albicans NCPF 1467(MIC=16µM),Candida albicans NCPF 1467(MBC=64µM),Human lung carcinoma NCI-H460(no activity data),Human breast adenocarcinoma MDA-MB-435S(no activity data),Human prostate adenocarcinoma PC-3(no activity data),Human breast adenocarcinoma MCF-7(IC50=7.222µM),Human melanoma A375(IC50=9.478µM),Human glioblastoma U87-MG(IC50=10.21)"
        }
    }
}